Source:http://linkedlifedata.com/resource/pubmed/id/12719710
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2003-4-29
|
pubmed:abstractText |
Survivin is expressed in most cancers but is undetectable in differentiated adult cells, and plays an important role both in the suppression of apoptosis and mitotic spindle checkpoint; thus it has attracted great interest as a potential drug target. In this study, we investigated the antigene and antiproliferative effects of triplex-forming oligodeoxynucleotides (TFO) targeting survivin in human lung carcinoma A549 cells. Survivin-specific TFOs form stable triplexes under physiological conditions as tested by electrophoretic mobility shift assays. Treatment of A549 cells with survivin-specific but not control TFOs at a concentration of 400 nM in the presence of uptake-enhancing liposome significantly reduced survivin protein level, inhibited cell proliferation, and induced cell apoptosis as demonstrated by immunoblot, cell number counting, and Annexin V-staining. Moreover, we found that the triplex-forming potential of TFOs measured in vitro does not necessarily correlate with the ability of TFOs to affect expression of a targeted gene in vivo. Our results indicate that targeting survivin is a promising alternative strategy for the development of novel anticancer therapeutics.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Annexin A5,
http://linkedlifedata.com/resource/pubmed/chemical/BIRC5 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers,
http://linkedlifedata.com/resource/pubmed/chemical/Inhibitor of Apoptosis Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Liposomes,
http://linkedlifedata.com/resource/pubmed/chemical/Microtubule-Associated Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Oligodeoxyribonucleotides
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0929-1903
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
403-10
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12719710-Annexin A5,
pubmed-meshheading:12719710-Apoptosis,
pubmed-meshheading:12719710-Cell Count,
pubmed-meshheading:12719710-Cell Division,
pubmed-meshheading:12719710-DNA Primers,
pubmed-meshheading:12719710-Electrophoretic Mobility Shift Assay,
pubmed-meshheading:12719710-Humans,
pubmed-meshheading:12719710-Inhibitor of Apoptosis Proteins,
pubmed-meshheading:12719710-Liposomes,
pubmed-meshheading:12719710-Lung Neoplasms,
pubmed-meshheading:12719710-Microtubule-Associated Proteins,
pubmed-meshheading:12719710-Neoplasm Proteins,
pubmed-meshheading:12719710-Nucleic Acid Conformation,
pubmed-meshheading:12719710-Oligodeoxyribonucleotides,
pubmed-meshheading:12719710-Tumor Cells, Cultured
|
pubmed:year |
2003
|
pubmed:articleTitle |
Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells.
|
pubmed:affiliation |
Department of Nuclear Medicine University of Ulm, Ulm, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|